Call for Abstract
Scientific Program
Annual Congress on Rare Diseases and Orphan Drugs, will be organized around the theme ““The voice of rare diseases - research and treatment—
Rare Diseases 2016 is comprised of 12 tracks and 56 sessions designed to offer comprehensive sessions that address current issues in Rare Diseases 2016.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
- Track 1-1Rare Infectious Diseases
- Track 1-2Primary adeno carcinoma of pancreas
- Track 1-3Renal cell carcinoma
- Track 1-4Barrett’s oesophagus high-grade dysplasia
- Track 1-5Malignant glioma
- Track 1-6Multiple myeloma
- Track 1-7Diabetes in the young
- Track 1-8Systemic Amyloidosis
- Track 1-9Hepatocellular carcinoma
- Track 2-1Rare Disease and Orphan Drug/Medicinal Product
- Track 2-2Orphan Drug Status Various Probabilities
- Track 2-3Challenges in Access to and Affordability of Medicines for Rare Diseases
- Track 2-4Regulation of drugs and biologics for rare diseases
- Track 2-5Opportunities to accelerate discovery research
- Track 2-6Development of new drugs and biologics for rare diseases
- Track 3-1Nonspecific symptoms
- Track 3-2Methodological issues
- Track 3-3The Parent’s Toolkit
- Track 3-4Insurance, Costs and Schools
- Track 3-5Rarity of the condition or disease
- Track 4-1Different types of Rare Diseases
- Track 4-2Vasculitides
- Track 4-3Autoimmune diseases
- Track 4-4Disorders of genetic origin
- Track 4-5Idiopathic pulmonary fibrosis
- Track 5-1Cancer Therapy and Treatments
- Track 5-2Cancer Pharmacology
- Track 5-3Pediatric Oncology
- Track 5-4Rare cancers are fundamentally different from common cancers
- Track 5-5The dichotomous development of rare cancers and common cancers
- Track 5-6The Genetics of Rare Cancers and Common Cancers
- Track 5-7Using rare diseases to understand carcinogenesis
- Track 6-1Normal patterns of aging
- Track 6-2Aging and immortality
- Track 6-3Premature aging disorders
- Track 7-1Infectious diseases in Humans
- Track 7-2Biological properties of the rare infectious diseases
- Track 7-3Rare diseases of unknown etiology
- Track 8-1Evidence-based policy making & commissioning
- Track 8-2Orphan drug status- Various Probabilities
- Track 8-3Clinical trials
- Track 8-4Clinical Pharmacology
- Track 9-1Clinical immunology of major diseases
- Track 9-2Autoimmune diseases
- Track 9-3Allergy and immunology
- Track 10-1Orphan Medicinal Products Regulation
- Track 10-2Economic considerations
- Track 10-3Public Private Partnerships
- Track 10-4Advance Market Commitments
- Track 11-1Early detection of rare diseases
- Track 11-2Discovery of free fetal DNA in maternal plasma
- Track 11-3Turner syndrome
- Track 11-4Future detection of rare genetic diseases
- Track 11-5Genome or Exome Sequencing
- Track 11-6Precision Medicine
- Track 11-7Genome Sequencing - Revolutionary Breakthrough for Rare Diseases
Enterpreneurs from any field can exhibit their products and can give a presentation on their products which should be helpful in business development and marketing.